Literature DB >> 11790609

The industrialization of drug discovery.

Jeffrey S Handen.   

Abstract

Mesh：

Year:  2002        PMID： 11790609     DOI： 10.1016/s1359-6446(01)02099-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  5 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

Review 2.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.

Authors:  David Cook; Dearg Brown; Robert Alexander; Ruth March; Paul Morgan; Gemma Satterthwaite; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

3.  Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.

Authors:  Mariusz Butkiewicz; Edward W Lowe; Ralf Mueller; Jeffrey L Mendenhall; Pedro L Teixeira; C David Weaver; Jens Meiler
Journal:  Molecules       Date:  2013-01-08       Impact factor: 4.411

4.  Parameter Optimization in High-Throughput Testing for Structural Materials.

Authors:  Alexander Bader; Anastasiya Toenjes; Nicole Wielki; Andreas Mändle; Ann-Kathrin Onken; Axel von Hehl; Daniel Meyer; Werner Brannath; Kirsten Tracht
Journal:  Materials (Basel)       Date:  2019-10-21       Impact factor: 3.623

Review 5.  The current state of drug discovery and a potential role for NMR metabolomics.

Authors:  Robert Powers
Journal:  J Med Chem       Date:  2014-03-03       Impact factor: 7.446
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.